Kratom
Kratom is a Southeast Asian plant whose leaves act as a mild stimulant at low doses and produce opioid-like effects at higher doses; it carries real dependence and toxicity risks and is federally unscheduled but banned in several U.S. states.
Overview
Kratom (Mitragyna speciosa) is a tree native to Southeast Asia, in the coffee family, whose leaves have been used traditionally in the region to relieve fatigue, pain, and opioid withdrawal. The leaves contain dozens of bioactive alkaloids; the two most studied are mitragynine and 7-hydroxymitragynine. People in the United States typically use dried, powdered leaf in capsules, brewed as tea, or as concentrated extracts. At lower doses kratom tends to produce mild stimulant-like effects, while at higher doses its effects are more opioid-like — sedation, pain relief, and euphoria. The U.S. Food and Drug Administration has not approved kratom for any medical use and considers it an unapproved drug and an unsafe food additive; it is not the same as an FDA-reviewed medication, and product contents and potency vary widely between brands.
Source: NIDA; FDA; Congressional Research Service
Chemistry & mechanism of action
Kratom's effects come mainly from its alkaloids acting on the brain's opioid system. Mitragynine, the most abundant alkaloid in the leaf, is converted in the body into 7-hydroxymitragynine, and both activate mu-opioid receptors — the same receptors targeted by drugs like morphine and oxycodone — though research suggests their effects only partly resemble those of conventional opioids. Mitragynine also appears to interact with adrenergic, serotonin, and dopamine receptors, which may explain the stimulant-like, arousing effects some people report at lower doses. Because the active compounds engage opioid receptors, kratom can produce tolerance, physical dependence, and withdrawal, and its effects and risks can shift depending on dose and on how concentrated a given product is.
Source: NIDA; peer-reviewed pharmacology literature
Effects
Reported effects depend heavily on dose. At lower doses people often describe increased energy, alertness, talkativeness, and sociability. At higher doses the effects shift toward those associated with opioids: pain relief, calm, sedation, and euphoria. Commonly reported unwanted effects include nausea, vomiting, constipation, itching, sweating, dizziness, dry mouth, and increased urination. Heavy or long-term use is associated with weight loss, fatigue, and — in some reports — liver problems. Regular use can lead to dependence, and stopping after sustained use can produce withdrawal symptoms similar to mild opioid withdrawal, such as irritability, muscle aches, runny nose, and craving.
Source: NIDA; FDA
Risks & harms
Although kratom is often marketed as a natural and therefore safe product, it carries real risks. Regular use can cause dependence and an opioid-like withdrawal syndrome. Kratom has been involved in poison-control calls and in deaths, though many reported deaths involved other substances taken at the same time — combining kratom with opioids, benzodiazepines, alcohol, or other depressants is particularly dangerous and can increase the risk of sedation and slowed breathing. Reported harms include liver injury, seizures, rapid heart rate, high blood pressure, and, with very high doses, the opioid risk of respiratory depression. A major current concern is concentrated 7-hydroxymitragynine products (tablets, gummies, shots) that are far more potent than natural leaf and behave much more like strong opioids. Product quality is inconsistent, and kratom products have been found contaminated (for example with Salmonella or heavy metals) or adulterated with other drugs. If someone may have overdosed or taken a dangerous combination, call 911; for poisoning call Poison Control at 1-800-222-1222. For help with dependence, SAMHSA's helpline is 1-800-662-4357.
Source: FDA; NIDA; Congressional Research Service
Subjective effects
low dose → alertness, energy, talkativeness, sociability; high dose → opioid-like sedation + euphoria
Onset
5–10 min
Duration
2–5 hr
Harmful effects
nausea, itching, sweating, dry mouth, constipation; addiction + withdrawal; long-term anorexia, weight loss, insomnia, hepatotoxicity; kratom psychosis; overdose + fatalities reported
Medicinal use
none in US (used traditionally + self-treatment of opioid withdrawal)
History
used by SE Asian laborers for centuries; opium substitute
Prevalence
NFLIS >4,000 mitragynine reports since 2010
Legal status (US)
NOT a controlled substance federally (state bans exist)
Source: Congressional Research Service; DEA; FDA
Drug laws and enforcement change and vary by country. This is not legal advice. Always confirm with the destination’s embassy or official drug authority before traveling, because penalties can be severe, including imprisonment.
Before you travel
Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →
Images
Visual references coming soon.
If it’s too intense
If an experience becomes overwhelming, the goal is to stay safe and let it pass, most difficult experiences ease as the drug wears off.
- Get to a calm, safe space with someone you trust who is sober and can stay with you.
- Cool down if you’re overheating, move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
- Sip water to thirst, but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
- Slow your breathing, long, slow exhales help settle a racing heart and anxiety.
- A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
- Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.
With opioids, slowed or stopped breathing is the emergency, if available, give naloxone and call 911 immediately; it can be given while you wait for help.
Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft, not yet medically reviewed.
Forensic dossier
Draft · every field is source-cited or marked “Unknown, pending review”Identity
- PubChem CID
- N/A — no single PubChem compound (mixture/class/plant/concept)
- IUPAC name
- N/A — no single PubChem compound (mixture/class/plant/concept)
- Molecular formula
- N/A — no single PubChem compound (mixture/class/plant/concept)
- SMILES
- N/A — no single PubChem compound (mixture/class/plant/concept)
- InChIKey
- N/A — no single PubChem compound (mixture/class/plant/concept)
- Synonyms / aliases
- mitragyna speciosa, ketum
Composition
- Composition
- Unknown — pending review (no single compound; needs an epidemiology / composition source)
Physical / pill characteristics
- Dosage form
- Unknown — pending review (no Rx/OTC label; illicit — pill visuals = FIRST-PARTY submissions only, never generated or scraped)
- Route
- Unknown — pending review
- Shape
- Unknown — pending review
- Color
- Unknown — pending review
- Imprint
- Unknown — pending review
- Score
- Unknown — pending review
Scheduling & legal status
- US schedule
- Unknown — pending review
- International
- Unknown, pending review
Effects, risks & interactions
- Effects
- Kratom is a plant from Southeast Asia whose leaves have long been used as a mild stimulant and for pain, and are now sold widely as a supplement, tea or capsule. Its effects are distinctively dual — opioid-like and stimulant-like at once — because its active alkaloids (mainly mitragynine and 7-hydroxymitragynine) act partly on the body's mu-opioid receptors, producing an incomplete opioid-like response, alongside stimulant properties. At lower amounts people report energy and alertness; at higher amounts, sedation, pain relief and euphoria. The alkaloids themselves are covered in their own dossiers.NIDA Kratom + PubChem mitragynine CID 3034396 ↗ · retrieved 2026-06-18
- Risks
- Because kratom acts on opioid receptors it produces dependence and a withdrawal syndrome (usually milder than classic opioids, but real), along with nausea, constipation and dizziness. A central harm-reduction issue is the unregulated market: products vary in strength and have been found contaminated with other substances, and deaths linked to kratom have nearly all involved other drugs or contaminants rather than kratom alone — so the supply, more than the leaf itself, is often the danger. Its opioid activity also means combining it with other opioids or CNS depressants raises the risk.NIDA Kratom + PubChem mitragynine CID 3034396 ↗ · retrieved 2026-06-18
- Interactions
- Unknown, pending review
Dosage
Pending medical reviewer
